August 12, 2019

China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China

SHANGHAI & ST. HELIER, Jersey–(BUSINESS WIRE)–Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative commercial stage biopharmaceutical company, and Novocure (NASDAQ: NVCR), a global oncology company with a proprietary platform technology called Tumor Treating Fields, today announced that the China National Medical Products Administration (NMPA) granted Innovative Medical Device Designation… Read More
learn more
August 12, 2019

China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China

SHANGHAI & ST. HELIER, Jersey–(BUSINESS WIRE)–Zai Lab Limited (NASDAQ: ZLAB), a Shanghai-based innovative commercial stage biopharmaceutical company, and Novocure (NASDAQ: NVCR), a global oncology company with a proprietary platform technology called Tumor Treating Fields, today announced that the China National Medical Products Administration (NMPA) granted Innovative Medical Device Designation… Read More
learn more
August 6, 2019

Novocure to Participate in Three Upcoming Investor Conferences

ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that it will participate in three upcoming investor conferences. Pritesh Shah, Novocure’s Chief Commercial Officer, will participate in the Wedbush PacGrow Healthcare Conference on August 14, 2019, in New York City. Mr. Shah’s presentation will begin at 8:35 a.m. Read More
learn more
August 6, 2019

Novocure to Participate in Three Upcoming Investor Conferences

ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that it will participate in three upcoming investor conferences. Pritesh Shah, Novocure’s Chief Commercial Officer, will participate in the Wedbush PacGrow Healthcare Conference on August 14, 2019, in New York City. Mr. Shah’s presentation will begin at 8:35 a.m. Read More
learn more